CYT 0.00% 13.0¢ cytopia limited

Partnering for development of JAK 3 kinase programmeanticipated...

  1. 1,055 Posts.
    Partnering for development of JAK 3 kinase programme
    anticipated to be concluded in the first quarter of 2006 which is getting pretty close - and the good thing is it will be tax free- doesnt get better than that!
 
watchlist Created with Sketch. Add CYT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.